{
    "clinical_study": {
        "@rank": "43496", 
        "arm_group": [
            {
                "arm_group_label": "DHA plus vitamin E", 
                "arm_group_type": "Experimental", 
                "description": "Cap DHA 460mg plus vitamin E 600mg per day"
            }, 
            {
                "arm_group_label": "VitaminE plus placebo", 
                "arm_group_type": "Active Comparator", 
                "description": "vitamin E 600 mg plus placebo"
            }, 
            {
                "arm_group_label": "placebo plus placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "DHA shaped placebo plus vitamin E shaped placebo"
            }, 
            {
                "arm_group_label": "DHA plus placebo", 
                "arm_group_type": "Active Comparator", 
                "description": "460 mg DHA plus placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "Since docosahexaenoic acid (DHA) level in sperm membrane has been shown to be decreased in\n      asthenozoospermic men, the investigators hypothesized that DHA supplementation may improve\n      it. Furthermore, the investigators added vitamin E to it to protect its unsaturated bonds\n      which are susceptible to oxidation and production of free oxygen radicals."
        }, 
        "brief_title": "The Effects of Administration of Combined Docosahexaenoic Acid and Vitamin E Supplements on Spermatogram and Seminal Plasma Oxidative Stress in Infertile Men With Asthenozoospermia", 
        "condition": "Asthenozoospermia", 
        "condition_browse": {
            "mesh_term": "Asthenozoospermia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Willing to participate in the study and filling out the informed consent form\n\n          -  should be infertile (no conception after 12 months intercourse without any\n             contraception)\n\n          -  age 20-45 y.o, idiopathic asthenospermia according to WHO criteria\n\n          -  normal hormonal profile\n\n        Exclusion criteria:\n\n          -  any infection in genitourinary (GU) tract\n\n          -  any anatomical abnormality in GU tract\n\n          -  any chronic disease during last 3 months\n\n          -  any surgery in GU tract\n\n          -  consumption of omega-3 fatty acids and/or vitamin E supplements during last 3 months"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01846325", 
            "org_study_id": "046401"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "DHA plus vitamin E", 
                    "VitaminE plus placebo"
                ], 
                "intervention_name": "vitamin E", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "DHA plus vitamin E", 
                    "DHA plus placebo"
                ], 
                "intervention_name": "DHA", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "VitaminE plus placebo", 
                    "placebo plus placebo", 
                    "DHA plus placebo"
                ], 
                "intervention_name": "placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Vitamin E", 
                "Alpha-Tocopherol", 
                "Tocopherols", 
                "Tocotrienols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 29, 2013", 
        "number_of_arms": "4", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ministry of Health"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "spermatogram", 
            "measure": "sperm motility", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01846325"
        }, 
        "responsible_party": {
            "investigator_affiliation": "National Nutrition and Food Technology Institute", 
            "investigator_full_name": "Dr Azita Hekmatdoost", 
            "investigator_title": "Dr", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "spermatogram", 
                "measure": "sperm count", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "description": "ELISA", 
                "measure": "seminal oxidative stress", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "National Nutrition and Food Technology Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Nutrition and Food Technology Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}